⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
MAZE News
Maze Therapeutics, Inc. Common Stock
Form 8-K
sec.gov
MAZE
Maze Therapeutics Announces $150 Million Registered Offering
globenewswire.com
MAZE
MazeBolt Continuously Validates DDoS Protection Against AI-driven DDoS Threats, for Leading Greek Financial Institution
globenewswire.com
MAZE
MAZE Shareholders Are Encouraged to Reach Out to Johnson Fistel for More Information About Potentially Recovering Their Losses
globenewswire.com
MAZE
Form 8-K
sec.gov
MAZE
Maze Therapeutics Announces Positive Topline Data from Phase 2 HORIZON Trial of MZE829 Demonstrating the First Clinical Proof-of-Concept in Patients with Broad APOL1-Mediated Kidney Disease
globenewswire.com
MAZE
Maze Therapeutics Reports Fourth Quarter and Full Year 2025 Financial Results and Recent Highlights
globenewswire.com
MAZE
Chronic Kidney Disease Market Poised to Expand Significantly During Forecast Period (2025-2034) as Demand for Early Diagnosis and Novel Therapies Increases | DelveInsight
prnewswire.com
MLYS
PROK
IRON
REGN
AMGN
MAZE
LLY
JNJ
LXRX
Maze Therapeutics to Participate in the TD Cowen 46th Annual Health Care Conference
globenewswire.com
MAZE
Zifo and Maze Therapeutics Partner to Power Precision Medicine
prnewswire.com
MAZE